| Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial G Mustacchi, R Ceccherini, S Milani, A Pluchinotta, A De Matteis, ... Annals of oncology 14 (3), 414-420, 2003 | 221 | 2003 |
| Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer … J Gligorov, D Doval, J Bines, E Alba, P Cortes, JY Pierga, V Gupta, ... The Lancet Oncology 15 (12), 1351-1360, 2014 | 159 | 2014 |
| The role of taxanes in triple-negative breast cancer: literature review G Mustacchi, M De Laurentiis Drug design, development and therapy, 4303-4318, 2015 | 151 | 2015 |
| Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer: The GRETA Trial. Group for Research on Endocrine Therapy in the Elderly. G Mustacchi, S Milani, A Pluchinotta, A De Matteis, A Rubagotti, A Perrota Anticancer research 14 (5B), 2197-2200, 1994 | 126 | 1994 |
| Gene expression profiling in breast cancer: a clinical perspective G Arpino, D Generali, A Sapino, L Del Matro, A Frassoldati, ... The Breast 22 (2), 109-120, 2013 | 116 | 2013 |
| Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: results of an Italian cooperative study F Boccardo, A Rubagotti, D Amoroso, M Mesiti, D Romeo, C Caroti, ... Journal of clinical oncology 19 (22), 4209-4215, 2001 | 114 | 2001 |
| Breast cancer in elderly women: a different reality? Results from the NORA study G Mustacchi, ME Cazzaniga, P Pronzato, A De Matteis, F Di Costanzo, ... Annals of oncology 18 (6), 991-996, 2007 | 85 | 2007 |
| Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA … F Boccardo, A Rubagotti, D Amoroso, P Sismondi, F Genta, I Nenci, ... European Journal of Cancer 28 (2-3), 673-680, 1992 | 77 | 1992 |
| Identification and validation of a new set of five genes for prediction of risk in early breast cancer G Mustacchi, MP Sormani, P Bruzzi, A Gennari, F Zanconati, D Bonifacio, ... International journal of molecular sciences 14 (5), 9686-9702, 2013 | 59 | 2013 |
| Modulating effect of lonidamine on response to doxorubicin in metastatic breast cancer patients: results from a multicenter prospective randomized trial D Amadori, GL Frassineti, A De Matteis, G Mustacchi, A Santoro, ... Breast cancer research and treatment 49, 209-217, 1998 | 59 | 1998 |
| HER2-positive metastatic breast cancer: a changing scenario G Mustacchi, L Biganzoli, P Pronzato, F Montemurro, M Dambrosio, ... Critical reviews in oncology/hematology 95 (1), 78-87, 2015 | 52 | 2015 |
| Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: pooled analysis of 2 consecutive trials F Boccardo, A Rubagotti, D Aldrighetti, F Buzzi, G Cruciani, A Farris, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 48 | 2007 |
| Advances in systemic therapy for metastatic breast cancer: future perspectives SP Corona, N Sobhani, A Ianza, G Roviello, G Mustacchi, M Bortul, ... Medical oncology 34, 1-16, 2017 | 47 | 2017 |
| Biology, prognosis and response to therapy of breast carcinomas according to HER2 score S Ménard, A Balsari, E Tagliabue, T Camerini, P Casalini, R Bufalino, ... Annals of oncology 19 (10), 1706-1712, 2008 | 45 | 2008 |
| A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low-and … Y Belkacemi, N Grellier, S Ghith, K Debbi, G Coraggio, A Bounedjar, ... European Journal of Cancer 135, 130-146, 2020 | 43 | 2020 |
| A phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer G Mustacchi, M Muggia, S Milani, R Ceccherini, ML Leita, C Dellach Annals of oncology 13 (11), 1730-1736, 2002 | 42 | 2002 |
| Italian Cooperative Group GRETA. Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled … G Mustacchi, R Ceccherini, S Milani, A Pluchinotta, A De Matteis, ... Ann Oncol 14 (3), 414-420, 2003 | 41 | 2003 |
| Early detection of breast cancer recurrences through periodic follow-up-Is it useless? S Ciatto, MR Del Turco, P Pacini, G Mustacchi, M Simonis, P Sismondi, ... Tumori Journal 71 (4), 325-329, 1985 | 37 | 1985 |
| Neo-adjuvant exemestane in elderly patients with breast cancer: a phase II, multicentre, open-label, Italian study G Mustacchi, M Mansutti, C Sacco, S Barni, A Farris, M Cazzaniga, ... Annals of oncology 20 (4), 655-659, 2009 | 35 | 2009 |
| Biological characteristics and medical treatment of breast cancer in young women—A featured population: results from the NORA study P Pronzato, G Mustacchi, A De Matteis, F Di Costanzo, E Rulli, I Floriani, ... International journal of breast cancer 2011 (1), 534256, 2011 | 34 | 2011 |
Michelino De LaurentiisIstituto Nazionale Tumori Napoli "Fondazione Pascale", Napoli, ITALY在 istitutotumori.na.it 的电子邮件经过验证
